Jean-François Formela, MD - World Medical Innovation Forum
WMIF Main Site
Jean-Francois Formela
This speaker appears at this event:

This speaker appeared in 2016, 2017, 2017 London, 2019, 2020, 2021, and 2022

Jean-François Formela, MD

Partner, Atlas Venture

Jean-François Formela is a partner and focuses on novel drug discovery approaches and therapeutics. He joined Atlas Venture in 1993 to build the U.S. life sciences franchise.

He is a director and co-founder of IFM Therapeutics, Intellia Therapeutics (NASDAQ: NTLA), Korro Bio, and Triplet Therapeutics. Jean-François also serves on the boards of Ikena Oncology (NASDAQ: IKNA) and Scorpion Therapeutics.

Some of his prior investments include Arteaus Therapeutics (acquired by Eli Lilly), CoStim Pharmaceuticals (acquired by Novartis), Exelixis (NASDAQ: EXEL) and Translate Bio (NASDAQ: TBIO, acquired by Sanofi).

Jean-François received his M.D. from Paris University School of Medicine and his M.B.A. from Columbia University.

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA